Acadia Healthcare Company, Inc. (ACHC) Stock Price & Analysis
Acadia Healthcare Company, Inc. (ACHC) rose 0.71% to USD 25.5 as of June 10, 2026 at 03:29 UTC, according to Nexqual real-time market data.
ACHC last closed at USD 25.32; the session ranged USD 25.16–25.68 on volume of 2,157,569 shares. Market capitalization is $2.35B, with a 52-week range of USD 11.43–30.2 (NMS). Source: Nexqual, June 10, 2026 at 03:29 UTC.
Key Statistics (as of June 10, 2026 at 03:29 UTC)
| Price | USD 25.5 |
|---|---|
| Change | ▲ 0.71% (up) |
| Previous Close | USD 25.32 |
| Open | USD 25.43 |
| Day Range | USD 25.16 – 25.68 |
| 52-Week Range | USD 11.43 – 30.2 |
| Volume | 2,157,569 shares |
| Market Cap | $2.35B |
| Exchange | NMS |
Technical Analysis (ACHC)
Nexqual's technical model rates ACHC "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 03:29 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.45 (neutral) |
| vs SMA50 | Below (USD 25.61) |
| MACD | -0.15 (negative) |
Analyst Ratings (ACHC)
Wall Street analysts rate ACHC "Buy" based on 14 analysts, with a mean price target of USD 28.86 (range USD 13–39), per Nexqual as of June 10, 2026 at 03:29 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 28.86 |
| High Target | USD 39 |
| Low Target | USD 13 |
| Buy / Hold / Sell | 8 / 5 / 1 |
Earnings (ACHC)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.36 |
| Revenue Estimate | $845.78M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.37 vs est 0.26 ▲ beat |
| 2025-12-31 | USD 0.07 vs est 0.01 ▲ beat |
| 2025-09-30 | USD 0.72 vs est 0.66 ▲ beat |
| 2025-06-30 | USD 0.83 vs est 0.71 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:29 UTC.
Financials & Fundamentals (ACHC)
| Total Revenue | $3.37B |
|---|---|
| Revenue Growth (YoY) | +7.60% |
| Gross Margin | +41.81% |
| Operating Margin | +10.12% |
| Profit Margin | -32.84% |
| ROE | -41.05% |
| Debt / Equity | 124.18 |
| Current Ratio | 1.71 |
| Total Cash | $158.47M |
| Total Debt | $2.69B |
| Free Cash Flow | $-216.92M |
Source: Nexqual, June 10, 2026 at 03:29 UTC.
Financial Health Score (ACHC)
Nexqual rates Acadia Healthcare Company, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:29 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 42%, operating 10% |
| Balance Sheet | Mixed — $158M cash vs $2.69B debt |
| Cash Flow | Weak — FCF negative: -$217M, burning cash |
| Efficiency | Critical — ROE -41%, ROA 4.2% |
Ownership (ACHC)
| Insider Ownership | +1.55% |
|---|---|
| Institutional Ownership | +146.06% |
| Shares Outstanding | 91.97M |
| Float | 85.14M |
| Short % of Float | +38.60% |
Source: Nexqual, June 10, 2026 at 03:29 UTC.
Leadership (ACHC)
Acadia Healthcare Company, Inc. is led by Debra K. Osteen (age 69), CEO & Director, per Nexqual as of June 10, 2026 at 03:29 UTC.
| CEO & Director | Debra K. Osteen (age 69) |
|---|---|
| Senior Vice President of Operations Finance | Timothy Sides (age 47) |
| Interim Chief Financial Officer | David M. Duckworth (age 45) |
| Senior Vice President of Investor Relations | Patrick Thomas Feeley C.F.A. |
| Operations Group President | Jeffrey Woods |
Major Backers & Investors (ACHC)
Notable institutional backers of Acadia Healthcare Company, Inc. include Wellington Management, FMR, LLC, Khrom Capital Management LLC, according to Nexqual as of June 10, 2026 at 03:29 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 9.87% |
| FMR, LLC | 7.47% |
| Khrom Capital Management LLC | 5.65% |
| Deerfield Management Company, L.P | 4.91% |
| DME Capital Management, LP | 4.91% |
| Morgan Stanley | 4.88% |
| Abrams Bison Investments, LLC | 4.76% |
| Fidelity | 3.09% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 27.71% |
| BlackRock | 19.76% |
Source: Nexqual, June 10, 2026 at 03:29 UTC.
From Acadia Healthcare Company, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.
- The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADUS | Addus HomeCare Corporation | USD 92.7 | ▲ 0.65% |
| EHC | Encompass Health Corporation | USD 104.19 | ▲ 0.17% |
| UHS | Universal Health Services, Inc. | USD 146.59 | ▲ 0.98% |
| SGRY | Surgery Partners, Inc. | USD 13.96 | ▲ 1.82% |
| MD | Pediatrix Medical Group, Inc. | USD 23.66 | ▲ 4.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:29 UTC. This page is informational and not investment advice.